Certain drugs and a host of nonpharmacologic therapies are key to treating patients who have nociplastic pain, a relatively ...
Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...
Patients with psoriasis, psoriatic arthritis, and axial spondylarthritis using ixekizumab have a low incidence rate of cerebro-cardiovascular events.
A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...
Pharmaceutical company Enlivex Therapeutics (ENLV) completed the initial dosing and follow-up of patients with psoriatic arthritis treated with ...
A research team co-led by scientists at the University of Arizona College of Medicine—Tucson found that an osteoporosis drug ...
The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for ...
Imagine being able to get a faster diagnosis of a condition based on your unique situation, be given personalised treatments based on what would be most effective for you and experience fewer, if any, ...